Boots Sold to Canada's Weston Family in £6.7bn High-Street Deal
 |
| A Boots pharmacy and beauty store on a British high street. The chain operates around 1,800 stores across the UK and Ireland. |
The sale was confirmed on Wednesday by Wittington Investments, the holding company of the Canadian arm of the Weston family, which agreed to buy the 177-year-old retailer from US private equity firm Sycamore Partners and the Pessina family. The transaction is expected to complete in early 2027, subject to regulatory approval.
A British institution changes hands again
Boots began life as a simple apothecary in Nottingham in 1849, when John Boot opened a small herbalist store offering an affordable alternative to traditional medicines. In the 177 years since, it has grown into a high-street institution, selling everything from prescriptions to premium beauty products, meal deals and travel accessories.
Today the chain operates around 1,800 stores and employs about 51,000 people across the UK and Ireland. In its most recent annual results, Boots generated £7.5 billion in sales — a 3.2% increase on the previous year.
But the business has faced serious challenges in recent years. Stores have seen lower footfall as more people switched to working from home rather than visiting town and city centre offices every weekday. The chain has closed hundreds of branches across the UK in recent years, and its debt burden under successive owners has drawn scrutiny.
Sycamore's brief and costly experiment
Sycamore Partners has owned Boots for just 18 months, making this one of the quickest flips in British retail history. The rapid resale marks the second change of ownership in just over a year, and it brings an end to months of speculation — reported in the trade press — over whether Boots might instead make a return to the London Stock Exchange.
The deal covers Boots' retail operations in the UK and Ireland, Boots Opticians, the No7 Beauty Company, and its businesses in Thailand and other franchised stores. Sycamore Partners and the Pessina family are set to keep control of the overseas assets, including Alliance Healthcare in Germany and the Benavides pharmacy chain in Mexico, according to reports.
Retail experts say the constant ownership churn has not helped. Catherine Shuttleworth, chief executive of Savvy Marketing, told reporters that shoppers were unlikely to see much change to stores in the coming months, but added that what they can "expect over time is an improved shopping experience as the new owners invest in the business."
She said health and beauty was a "massive area for growth", and that fresh investment from its new ownership would make Boots "great again". But she also warned that "the chopping and changing of owners had been an unhelpful distraction" for the business.
Who are the Westons?
The Weston family is one of the world's wealthiest retail dynasties. The Canadian arm, through its holding companies, controls grocery giant Loblaws and the Shoppers Drug Mart pharmacy chain — experience that analysts say makes Boots a natural fit.
The family has deep roots in British retail too. It previously owned the luxury London department store Selfridges, which it sold in 2022 in a deal reported at $4 billion, and it is the majority owner of Associated British Foods, the parent company of high-street fashion giant Primark. One report puts the family fifth on the Sunday Times Rich List this year, with a combined fortune of almost £19 billion.
Galen Weston, chairman of Wittington Investments, who is expected to become chairman of Boots, said the chain played "a vital role in everyday life across the UK and Ireland."
"We see a meaningful opportunity to make a great business even better through stable long-term ownership, continued capital investment, and the renewed operational focus required to serve customers with excellence for generations to come," he said.
Reports also note that former Currys chief executive Alex Baldock was recently appointed as Boots' chief executive, giving the new owners an experienced retail operator in place.
 |
| Inside a Boots store, combining pharmacy services with beauty, food and general retail. |
What This Means
For shoppers, analysts say the short-term impact will be minimal. Store closures, product ranges and loyalty programmes are unlikely to change overnight, and the deal still needs to clear regulatory hurdles before it completes.
But the symbolism is significant. Boots is one of the few remaining giants of the British high street still flying a British flag of sorts — and this sale puts it in the hands of long-term owners with a track record in exactly the two sectors where Boots makes its money: pharmacy and everyday retail.
The Weston family has consistently presented itself as a patient, long-term investor, in contrast to the private equity model that has reshaped so much of British retail. Its pharmacy experience with Shoppers Drug Mart in Canada is directly relevant: Boots' own healthcare services have been one of the few bright spots in its recent performance, with the company reporting stronger demand for its pharmacy services.
For the high street itself, the deal is a vote of confidence at a difficult moment. Footfall is still recovering from the work-from-home shift, and several big names have shrunk their store estates. A £6.7 billion bet on the future of physical retail is, at minimum, a signal that smart money still sees value in the high street.
 |
| A Boots branch on a British high street. The sale to the Weston family is expected to complete in early 2027, subject to regulatory approval. |
What Happens Next
The deal is expected to complete in the first quarter of 2027, subject to regulatory approval. Competition regulators in the UK and Ireland will scrutinise the transaction, though analysts do not expect major obstacles.
The immediate question is what the new owners do with Boots' sprawling estate. The chain has closed hundreds of branches in recent years; the Westons' promise of capital investment could mean refurbishments rather than further closures, though the new chairman has given few specifics.
Shuttleworth's verdict sums up the cautious optimism: shoppers should not expect overnight transformation, but "an improved shopping experience" over time, with health and beauty — already Boots' strongest category — as the priority for investment.
For the 51,000 employees across the UK and Ireland, the change of ownership brings a familiar mix of hope and uncertainty. Private equity ownership is often associated with cost-cutting; a family owner promising "stable long-term ownership" will raise hopes of a steadier hand — but the proof, as always, will be in what happens to stores, jobs and prices in the months after the deal completes.
No comments